Epineuron is a clinical stage bioelectronic medicine company developing the world’s first device to supercharge nerve regeneration. Our device merges innovations in neuroscience and surgical procedures to deliver regenerative therapy to damaged peripheral nerves, ultimately helping patients regain functions they have lost. Our lead product, the Nerve Bandage™, has been designated a Breakthrough Device by the FDA in recognition of the impact our technology can have in improving patient outcomes.
Founders
Sergio Aguirre
Co-Founder
Mike Willand
Co-Founder
Featured Stories

Epineuron Technologies Closes Financing for Breakthrough Neuroregenerative Solution
Congratulations to The Forge alumnus Epineuron Technologies Inc., that announced the completion of a financing round led by leading medical technology...